Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
100.49
+6.69 (7.13%)
At close: Dec 5, 2025, 4:00 PM EST
102.49
+2.00 (1.99%)
After-hours: Dec 5, 2025, 5:49 PM EST
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.19 billion as of December 5, 2025.
Market Cap
1.19B
Enterprise Value
1.14B
1-Year Change
n/a
Ranking
Category
Stock Price
$100.49
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.19B, an increase of 726.18%. That is a compound annual growth rate of 782.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.19B | 783.33% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |